About
About YUANPIN

Yuanpin Cell Biotechnology Group Co., Ltd. is a high-tech enterprise specializing in the storage of human biological resources (including stem cells and immune cells), production and preparation of cell-based preparations and derivative products, clinical research on cellular technologies, cell therapy development and clinical translation, as well as biomedical health big data management.
Learn more
Core Module

Corporate Events

January 2025

On 27th January, the IND application for the new indication of Human Amniotic Mesenchymal Stem Cell Injection, a Class 1 new biological drug independently developed by Genpine Biologics, was formally accepted by CDE for the treatment of chronic obstructive pulmonary disease.

December 2024

On 19th December, ‘Human Amniotic Membrane Mesenchymal Stem Cell Injection’, the world's first independently researched and developed biological new drug, obtained IND approval, which is one of the rare clinical applications for a class 1 stem cell new drug in Hunan Province.

December 2024

On 18th December, Jiang Dafei, Vice Governor of Hunan Provincial People's Government, and his delegation visited Zhongnan Yuanpin Stem Cell Technology Park to investigate the biomedical industry chain.

December 2024

On 11th December, Genpine Bio was successfully selected as one of the ‘Gazelle’ enterprises in Changsha in 2024.

December 2024

On 10th December, the first overseas service centre of Genpine Bio was established in Malaysia.

September 2024

Changsha Stem Cell and Regenerative Medicine Industrial Technology Research Institute participated in the drafting of the group standard ‘Code of Safety Management for Immune Cell Separation, Preparation and Storage’ released!

September 2024

The IND application of Human Amniotic Membrane Mesenchymal Stem Cell Injection, a Class 1 biological product independently developed by Yuanpin Biologicals, was formally accepted by the Centre for Drug Evaluation (CDE) of the State Drug Administration (Acceptance No.: CXSL2400674).

August 2024

Changsha Stem Cell and Regenerative Medicine Industrial Technology Research Institute participated in drafting and formulating the group standard ‘Autologous NK Cells Induced Activation Cultivation Methods and Release Specification’, which was formally released!

May 2024

Yuanpin Biotech and Hunan Academy of Traditional Chinese Medicine reached a strategic cooperation!

April 2024

Yuanpin Biotech was recognised as a speciality, speciality and new small and medium-sized enterprise in Hunan Province in 2024!

January 2024

As the first batch of scientific and technological ethical review organisations in Hunan Province in 2023, Genpine Bio's Life Science and Technology Ethics Committee held its first review meeting.

November 2023

In accordance with the company's strategic deployment and operational development needs, in order to promote the nationwide business development, the company name was changed and registered as ‘Yuanpin Cellular Biotechnology Group Co.

September 2023

Yuanpin Biotech entered into a strategic cooperation with Yuantai Biotechnology, in which both parties will cooperate in the field of immune cell therapy, and jointly build a closed-loop industrial chain with the trinity of ‘cell storage - drug R&D - clinical transformation’.

June 2023

Creating a new pattern of biosafety, Yuanpin Biotech hosted the 7th Biosafety Forum! Scientific and technological innovation again! Yuanpin Biotech was recognised as the Hunan Provincial Enterprise Technology Centre in 2023!

October 2022

Approved by the Ministry of Science and Technology of China Human Genetic Resources Conservation to build and operate a cell bank, the first cell bank in Hunan Province!

September 2022

Source product biological approved China (Hunan) free trade test zone.Stem cell clinical frontier medical technology research first pilot units

October 2022

Yuanpin Hospital started trial operation, Zhongnan Yuanpin Stem Cell Science and Technology Park Regeneration (Hunan) Free Trade Law Inspection Zone Work Office 2 medical industry chain in the country for the first time to achieve a closed loop!

December 2021

Yuanpin Biotech has set up branches in Liaoning, Shaanxi and Yunnan, opening a national layout mode!

December 2021

Tongji University, Changsha Municipal Government, Changsha Economic Development Zone Management Committee and Genpine Bio signed a contract to establish ‘Changsha Stem Cell and Regenerative Medicine Industrial Technology Research Institute’!

November 2020

The project of ‘Amniotic Membrane Mesenchymal Stem Cells for Ovarian Hypogonadism’ was approved by Hunan Provincial High-tech Industry Science and Technology Innovation Leadership Programme!